FMR1 and fragile X syndrome: Regarding the molecular mechanisms that are involved with impaired neurogenesis of FXS, it is hard to point to major downstream targets/specific pathways that play a central role in disease pathology since FMRP, as mentioned earlier, has many (hundreds to thousands [110]) downstream gene targets.